Trial Profile
A Prospective, Non-Interventional, Multicenter study to evaluate the effcacy of Azelastine/fluticasone-propionate (MP-AzeFlu) in patients with moderate-to-severe Allergic rhinitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 11 May 2018 New trial record